ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

NRXS Neuraxis Inc

2.70
-0.10 (-3.57%)
20 Jun 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Neuraxis Inc NRXS AMEX Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.10 -3.57% 2.70 15:00:10
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
2.85 2.50 2.90 2.70 2.80
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
07/6/202408:00GLOBENeurAxis Announces New Submission to the FDA for the..
22/5/202407:00GLOBENeurAxis Reports First Quarter 2024 Financial Results
21/5/202408:00GLOBENeurAxis to Participate in the Lytham Partners Spring 2024..
20/5/202415:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
16/5/202408:00GLOBENeurAxis Announces New Medical Policy Coverage For Nearly..
15/5/202415:30GLOBENeurAxis to Host First Quarter 2024 Results and Business..
15/5/202415:15EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
23/4/202408:00GLOBENeurAxis Announces New Medical Policy Coverage in North..
09/4/202415:05GLOBENeurAxis Reports Fourth Quarter and Fiscal Year 2023..
01/4/202415:15GLOBENeurAxis to Host Fourth Quarter and Full Year 2023 Results..
27/3/202408:00GLOBENeurAxis Announces IB-Stim Results from a Large, Pediatric,..
11/3/202408:00GLOBENeurAxis Announces Highmark BCBS Policy Coverage
11/3/202407:50EDGAR2Form 8-K - Current report
04/3/202408:00GLOBENeurAxis Announces Blue Cross and Blue Shield of Kansas City..
27/2/202410:00GLOBENeurAxis to Present at Oppenheimer 34th Annual Healthcare..
15/2/202416:00EDGAR2Form 8-K - Current report
31/1/202408:15EDGAR2Form 8-K - Current report
20/12/202308:00GLOBENeurAxis, Inc. Issues Letter to Shareholders from Brian..
19/12/202316:05EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
19/12/202316:00EDGAR2Form 8-K - Current report
20/11/202316:30GLOBENeurAxis Reports Third Quarter 2023 Financial Results
20/11/202316:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/11/202308:00GLOBENeurAxis Announces CareFirst BCBS Policy Coverage
14/11/202308:00GLOBENeurAxis Secures $3 Million Financing
08/11/202308:00GLOBENeurAxis Signs Exclusive Option Agreement with University of..
26/9/202308:00GLOBENeurAxis Announces Results of Comparative Study of IB-Stim™..
22/9/202315:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
21/9/202307:30EDGAR2Form 8-K - Current report
21/9/202307:00GLOBENeurAxis Reports Second Quarter 2023 Financial Results
13/9/202315:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
13/9/202308:00GLOBENeurAxis to Present at the Gilmartin Group Emerging Growth..
12/9/202308:00GLOBENeurAxis Announces Publication of Prospective Study Showing..
29/8/202310:49APSNews Brief: NeurAxis Inc.
29/8/202308:00GLOBENeurAxis Highlights Pediatric Post-Concussion Clinical Study
24/8/202308:00GLOBENeurAxis Highlights Strength of its Board of Directors
22/8/202308:00GLOBENeurAxis Highlights Two Independent Studies Showing Benefits..
17/8/202308:02GLOBENeurAxis Announces Over $8 Million in IB-Stim™ Revenue
10/8/202308:00GLOBEExchange Listing Client, Neuraxis, Inc., Successfully..